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ABSTRACT: A promising material in medicine, electronics, opto electronics, 
electrochemistry, catalysis, and photophysics, Al(III) phthalocyanine chloride 
tetrasulfonic acid (AlPcS4) is investigated at biological interfaces of human breast 
tissue by means of steady state and time resolved pump−probe spectroscopies: IR, 
Raman, UV−vis, fluorescence, and electronic transient absorption by pump−probe 
spectroscopy. Spectrally resolved pump−probe data were recorded on time scales 
ranging from femtoseconds to nanoseconds and give insight into molecular 
interactions and primary events in the interfacial region. The nature of these fast 
processes and pathways of the competing relaxation processes from the initially 
excited electronic states in AlPcS4 films and at biological interfaces of human breast 
cancerous and noncancerous tissues is studied. Comparison between photochemical 
dynamics in the biological environment of the human breast tissues and that occurring 
in aqueous solutions is presented. The excited state absorption (ESA) decays and 
bleaching recovery of the ground state have been fitted in the time window extending
to nanoseconds (0−1 ns). We found that the excited state dynamics of AlPcS4 at biological interfaces of human breast tissue is
extremely sensitive to the biological environment and differs drastically from that observed in solutions and films. We
demonstrated that the ultrafast dynamics at biological interfaces is described by three time constants in the ranges of 110−170 fs,
1−7 ps, and 20−60 ps. We were able to ascribe these three time constants to the primary events occurring in phthalocyanine at
biological interfaces. The shortest time constants have been assigned to vibrational wavepacket dynamics in the Franck−Condon
region down to the local minimum of the excited state S1. The 1−7 ps components have been assigned to vibrational relaxation
in the excited and ground electronic states. In contrast to the dynamics observed in aqueous solutions with the components in
the range of 150−500 ps assigned to decay from S1 to the ground electronic state, these slow components have not been
recorded in human breast tissue. We have shown that the lifetimes characterizing the first excited state S1 in the interfacial
regions of the breast tissue are markedly shorter than those in solution. It suggests that molecular structures responsible for
harvesting of the light energy in biological tissue find their own ways for recovery through some special features of the potential
energy surfaces such as conical intersections, which facilitate the rate of radiationless transitions. We found that the dynamics of
photosensitizers in normal (noncancerous) breast tissue is markedly faster than that in cancerous tissue.
1. INTRODUCTION
Phthalocyanines are promising materials in medicine, elec
tronics, opto electronics, electrochemistry, and catalysis. The
growing numbers of phthalocyanines play an important role as
photosensitizers in photodynamic therapy (PDT), inactivation
of antibiotic resistant microorganisms,1−77 and as materials in
low gap semiconducting electronic devices.78 Localization,
tumor affinity, and phototoxicity of photosensitizers are
known to be determined by vascular permeability and
interstitial diffusion, which depend on many factors such as
molecular size, configuration, charge, and hydrophilic or
lipophilic properties.79 Charge determines the anionic, cationic,
and neutral character of photosensitizers and is an important
factor in the cellular uptake and photodynamic efficacy in
photodynamic therapy (PDT).74 Electrostatic interactions play
important role in binding of photosensitizers to a membrane as
the largest difference in the photodynamic activity of cationic
and anionic phthalocyanines was observed in a membrane
containing negatively charged lipids. It has been found that a
water soluble tetrasubstituted cationic aluminum phthalocya
nine (AlPcN(4)) revealed efficient binding of this photo
sensitizer to phospholipid membranes as compared with
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anionic tetrasulfonated aluminum and zinc phthalocyanine
complexes.75 It has been shown that the increase in the degree
of sulfonation of phthalocyanine progressively reduced its
affinity for the lipid bilayer.75 It has been suggested that binding
of tetrasulfonated metallophthalocyanines to phospholipid
membranes is determined primarily by metal−phosphate
coordination.76 The hydrophilic or lipophilic property of the
photosensitizers is related to their water solubility, which
controls aggregation properties, and singlet oxygen production
efficiency. Among the hydrophilic photosensitizers, anionic
derivatives with sulfo substituents (Figure 1) such as AlPcS4 are
one of the best targets for a new generation of photosensitizers.
Lipophilic phthalocyanine derivatives are reported to have a
higher tumor affinity, but water soluble phthalocyanines are
considered to have higher phototoxicity.77,78 Initial subcellular
localization of each photosensitizer is dependent upon the
hydrophobicity and plasma protein binding. Depending on the
charge and hydrophilic or lipophilic property the photo
sensitizer is localized in various cytoplasmic membranous
structures of certain types of cells or their compartments such
as a membrane surfaces, endosomal compartments, organelles,
and cytoplasm. While anionic phthalocyanines have been
reported to have higher selectivity binding than cationic
phthalocyanines, some cationic compounds may also target
specific sites such as mitochondria.79 Mitochondria have been
proposed to be one of the most effective subcellular targets for
photodamage.79−83
Another way to direct the photosensitizer to specific sites of
the cell or tissue is to use specific targeting biomolecules84−86
(Figure 2) such as conjugated antibodies directed against
tumor associated antigens or vascular antigens, such as the ED
B domain.87
Progress made since the mid 1990s has led to development
of photosensitizers that can be localized in the mitochondria,
plasma membrane, lysosomes, and nuclei.88,89 The specific
targeting nanocarriers approach combined with laser spectros
copy and Raman imaging has the potential to revolutionize
cancer diagnosis and therapy.89
In this paper we focus on biological interfaces that the
photosensitizer may encounter after suspension and adsorption
Figure 1. Anionic and cationic photosensitizers.
Figure 2. Antibody−phthalocyanine−gold nanoparticle bioconjugate.
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in a biological medium (noncancerous and cancerous human
breast tissue) and after interacting with cells components. We
will present the dynamics of phthalocyanine at biological
interfaces of human breast tissues in the time window ranging
from femtosecond to nanoseconds and compare it with the
dynamics of the AlPcS4 film on the glass support as well as with
the dynamics in aqueous solutions. Characterizing the solid−
liquid interface is a key challenge in understanding the nano−
bio interface photochemistry of photosensitizers and energy
dissipation in electronic devices. Although we often assume that
steady state behavior with the bulk properties of solutions can
be translated to the solid phase, this approach must be
considerably revised when considering the nano−bio interface.
The effects of aggregation on the absorption and emission
spectra of metallophthalocyanines in liquid solutions are well
documented,44−53 but much less information has been
accumulated on the solid phases, particularly biological
interfaces. Films of phthalocyanines have become relevant in
advanced devices like electrochromic displays, optical limiters,
light emitting diodes, recordable digital discs, organic con
ductors, lasers, nonlinear optical elements, etc. In these
applications properties such as conductivity, optical absorbance,
and photoconductivity in the solid state phase are impor
tant.72,90−93 Dynamics of primary events upon light excitation
in thin films is even more important than the steady state
behavior. There are much less papers reporting on primary
events in phthalocyanines occurring on the femtosecond and
picosecond scale.1,4,55,68,70,75,76,94−97
This paper reports recent progress obtained in our laboratory
on understanding light energy collection and dissipation at
biological interfaces, with special emphasis on the primary
events in light initiated photosensitizers accumulated in cancer
ous and noncancerous human breast tissues. Detailed under
standing of energy dissipation paths will reveal mechanisms that
mediate light induced signal transduction as well as the role of
photoreceptors in photostability protection and reparation
mechanisms in living cells and tissues. Ultrafast spectroscopies
have played an important role in the study of a number of
biological processes and provided unique information on
primary events and the mechanism of energy.98 The
experimental methods used in this paper are based on the
linear and nonlinear responses such as Raman spectroscopy,
Raman imaging, IR, and UV−vis spectroscopies and pump−
probe transient electronic absorption spectroscopy.
In this paper Al(III) phthalocyanine chloride tetrasulfonic
acid (AlPcS4) has been chosen (Figure 3) to serve as a model
phothosenistizer to study the efficiency of primary processes
occurring upon excitation of the chromophore.
We wish to elucidate processes responsible for fast dynamics
of AlPcS4 in various microenvironments, particularly at the
biological interface of human breast tissue, occurring on the
time scale from femtoseconds to nanoseconds monitored by
pump−probe transient absorption spectroscopy when excited
by femtosecond laser pulses centered at 677 nm, corresponding
the absorption maximum of the Q band of phthalocyanines.
2. EXPERIMENTAL SECTION
Phthalocyanine. Al(III) phthalocyanine chloride tetrasul
fonic acid was purchased from Frontier Scientific, Inc. (AlPcS
834). Water was deionized before preparing the solutions.
Steady-State UV−Vis Absorption Measurements.
UV−vis absorption electronic spectra were measured with a
Varian Cary 5E spectrophotometer in 2 and 0.10 ± 0.005 mm
detachable quartz cells (Hellma). Spectra were recorded at 293
K for aqueous solutions at concentrations of c = 10−3 M in the
thin sections of 6 μm of human breast samples of cancerous
and noncancerous tissues stained with AlPcS4.
Pump−Probe Transient Absorption Spectroscopy.
The source of femtosecond pulses was a mode locked titanium
sapphire femtosecond laser (MIRA, Coherent, 800 nm, 76
MHz, 9 nJ, <200 fs) pumped with a diode pumped solid state
laser (VERDI V5, Coherent, 532 nm). The fundamental beam
is amplified with a Ti:sapphire regenerative amplifier (Coherent
Legend USP, 800 nm, 1 kHz, 3 mJ, 50 fs). The regenerative
amplifier is pumped with a diode pumped Nd:YLF laser
(JADE, Thales Laser, 527 nm, 1 kHz, 20 mJ, <200 ns). The
pulse was split in two and further amplified in a dual single pass
amplifier (Coherent Elite Duo, 800 nm, 1 kHz, 2 × 4.5 mJ, 50
fs). This amplifier is pumped by a high power Nd:YLF laser
(Evolution, Coherent, 527 nm, 50 mJ, <200 ns). The output of
the laser system was split, and two 1 mJ laser pulses were used
to pump two optical parametric amplifiers (OPA, model
TOPAS from Light Conversion). These OPA combined by
frequency conversion modules generate femtosecond pulses
tunable in the 300 and 2600 nm range. The energy of the pump
pulse was adjusted to 2 μJ in water experiments and 700 nJ or
less in experiments with DMSO. The energy of the probe pulse
was at least 100 times lower than the energy of the pump pulse.
Pump and probe pulses were overlapped on a 1 mm optical
path of a cell containing the AlPcS4 solution. The solution was
circulating in the cell by a magnetic stirrer in order to minimize
thermal lensing and photoquenching effects. The time delay
between the pump and the probe pulses was adjusted by a
motorized translation stage that has a spatial resolution of 1.5
μm. Transient absorption signals were measured with two
silicon photodiodes (Thorlabs, TDS 1000) placed before and
after the sample, which measure the initial (I0) and transmitted
intensity of the probe beam (It), respectively. I0 was normalized
with respect to the intensity of the pump beam, which was
measured with the same type of photodiode. The absorption
signal S(t) was calculated as log(I0/It). The transient absorption
signal ΔA(t) was computed by subtracting the absorption signal
measured with and without the pump pulse. For that reason the
Figure 3. Hydrophilic and anionic character of AlPcS4.
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pump beam was chopped at 40 Hz. The typical measurement
error of ΔA was better than 10−3.
Patients and Samples. All procedures were conducted
under a protocol approved by the institutional Bioethical
Committee at the Medical University of Lodz, Poland (RNN/
29/11/KE, RNN/30/11/KE, RNN/31/11/KE). We studied
ductal and lobular carcinoma (in situ and infiltrating) as well as
various benign changes including benign dysplastic and
neoplastic lesions. The total number of patients was 222.
Raman spectroscopy and Raman imaging have been employed
to analyze breast cancer specimens. Breast tissue samples were
taken during a surgical operation. The research did not affect
the course of the operation or treatment of the patients.
In order to visualize and identify tissue structures by Raman
imaging and IR spectroscopy we developed the method of
processing surgical specimen. First, we checked the effect of
standard steps used in histology protocols on the Raman
measurements, such as formalin fixation, paraffin embedding,
and coating to adhere a cover glass to a microscope slide. We
found that using the standard chemical fixative to preserve
tissue from degradation−10% neutral buffered formalin (4%
formaldehyde in phosphate buffered saline) does not introduce
changes in the Raman spectra. This conclusion is based on
comparison between the results obtained for fresh tissue
samples (167 patients) and those for formalin−fixed tissues (55
patients). In contrast, paraffin embedding is not the appropriate
protocol for both Raman and IR measurements. The
paraffinization protocol contains a few steps: dehydration
with alcohols, clearing with xylene, infiltrating with the
embedding material of paraffin vax, and embedding tissues
into paraffin blocks, which may introduce artifacts in Raman
spectra resulting from tissue processing. We found that the
frozen section procedure, where the frozen fresh tissue (or
formalin fixed tissue) is sliced using a microtome (Microm HM
550, Sermed) into 2−6 μm thick sections, is the most
appropriate protocol for Raman and IR measurements. Fresh
tissue obtained from surgery is snapped in liquid nitrogen.
Frozen fresh tissue blocks are stored at −80 °C until needed for
processing. In most cases they are used within a few hours from
preparation. A process similar to bread loafing has been
employed to cut the surgical specimens into 4 or more sections
from the tumor mass and from the safety margins of the excised
tumor where no carcinoma was detected by the histopathol
ogists. Frozen tissue is cut into thin sections at −25 °C for
unfixed tissue and −17 °C for fixed tissue. This procedure
ensures that the very thin, adjacent sections represent the same
breast structures and the same type of pathology. Thin slices
without staining are mounted on a glass slide for Raman
measurements and on BaF2 windows for IR and UV−vis
measurements. For both IR and Raman measurements the
tissue specimen is not covered with another layer of glass
attached to the sample, because a specific adhesive introduces
artifacts due to vibrational spectra of the adhesive in the same
spectral range.
The adjacent sections of tissue are mounted on glass slides,
stained with hematoxylin and eosin, and covered with another
layer of glass with a specific adhesive (Histokitt, Glaswar
enfabrik Karl Hecht GmbH & Co KG, CAS no. 1330 20 7) for
histology examination. After Raman measurements the slices
are stained and examined by pathologists. As the quality of the
slides produced by the frozen section is lower for purposes of
histology examination than formalin fixed, wax embedded
tissue processing, the standard histology processing is addi
tionally performed for a more accurate diagnosis for each
patient. Histological analysis was performed according to
standard histology protocols by professional medical doctors,
board certified as pathologists, from the Medical University of
Lodz, Department of Pathology, Chair of Oncology.
Raman Spectroscopy and Imaging. All Raman images
and spectra reported in this paper were acquired using a Raman
spectrometer Ramanor U1000 (Jobin Yvon, JY) excited with
the ion Ar laser (514 nm) and alpha 500 RA (WITec, Ulm,
Germany) model consisting of an Olympus microscope,
coupled with an UHTS spectrometer and a Newton CCD
camera operating in standard mode with 1024 × 127 pixels, at
−64 °C with full vertical binning. The laser beam doubled SHG
of the Nd:YAG laser (532 nm) is focused on the sample with a
numerical aperture, NA, of 0.50 to the spot of 200 nm. The
average laser excitation power was 10 mW.
The 2D array images of tens of thousands of individual
Raman spectra were evaluated by the basis analysis method. In
this data analysis method each measured spectrum of the 2D
spectral array is compared to basis spectra using a least squares
fit. Such basis spectra are created from the average spectra from
three different areas in the sample. The weight factor in each
point is represented as a 2D image of the corresponding color
and mixed coloring component.
Infrared Spectroscopy. IR spectra were recorded using
Specord M 80, Germany. Specord M80 is a double beam
spectrometer recording in the range from 4000 to 200 cm−1
(2.5−50 μm) with accuracy changing of from ±0.8 to ±0.3 cm
−1 depending on the spectral range. Spectra were scanned with
a step of 4 cm−1 and recorded in the range 800−4000 cm −1 at
293 K.
3. RESULTS
In this section we present the results for AlPcS4 at the interface
of the noncancerous and cancerous human breast tissues by
Raman, IR, and UV−vis steady state spectroscopies as well as
time resolved transient electronic absorption by pump−probe
spectroscopy.
In order to identify human breast structures and the
corresponding biochemical constituents that produce the
vibrational patterns of behavior, we recorded the histological
images and Raman and IR spectra for human breast tissues of
the same patient P91. Histopathological images of breast tissue
from the safety margin of the tumor mass (normal, non
cancerous) and from the tumor mass (cancerous) are presented
in Figure 4.
One can see that normal breast tissue consists mainly of fatty
tissue with embedded ducts and blood vessels (Figure 4a).
Fatty tissue is hydrophobic as it is formed of glycerol
monooleate (GMO).99 Cancerous tissue is dominated by
epithelial cells, which produce milk and are lined with the ducts
Figure 4. Histological images of the noncancerous (a) and cancerous
(infiltrating ductal carcinoma) (b) human breast tissue of patient P91.
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of the breast. Epithelial cells are the origin of 80% of all breast
tumors. They contain no blood vessels, so nourishment is
provided via diffusion of substances from the connective tissue
(Figure 4b). The surface of the cancerous tissue is hydro
philic,100 and the level of various proteins is markedly elevated
during disease development.
Steady-State Raman Scattering. Figure 5 shows the
Raman spectra of typical noncancerous and cancerous human
breast tissue of patient P91 of a total number of 222 patients.
The first observation that one makes when confronting the
results are noticeable differences between the Raman spectra of
noncancerous breast tissue surrounding the tumor from the
safety margin (Figure 5a) and those of cancerous breast tissue
from the tumor mass (Figure 5b). First, comparison between
the Raman spectra demonstrates that noncancerous tissue
contains Raman peaks characteristic for glycerol monooleate
derivatives,101−105 which are not observed in the Raman spectra
of cancerous tissue. Second, detailed inspection of Figure 5
demonstrates that the strongest signals in the Raman spectrum
of noncancerous tissue originate from carotenoids at 1158 and
1518 cm−1, which are not visible in the Raman spectrum of
cancerous tissue. It clearly indicates that noncancerous breast
tissue contains a significant contribution of glycerol monooleate
derivatives originating from the adipose tissue that acts as a
dynamic reservoir for carotenoids filling the spaces around the
lobules and ducts and fatty acids that make up the cell
membrane and nuclear membrane. In contrast, cancerous
breast tissue does not contain any carotenoids.
Third, a marked distinction can be observed in the lipid−
protein profiles in the region of 2800−3000 cm−1, where the
contribution from the monounsaturated fatty acids that are
common constituents of triglycerides of the adipose tissue
dominate the Raman spectrum of noncancerous tissue in
contrast to the Raman spectra of cancerous tissue. We have
shown101−105 that the Raman spectra demonstrate a mixed
lipid−protein profile. This finding corresponds to the fact that
in contrast to normal cells abnormal cells divide in an
uncontrolled process of cell growth that synthesizes large
amounts of proteins.
Steady-State IR Absorption. To obtain complementary
information on vibrational features of noncancerous and
cancerous tissues it would be very interesting to compare the
Raman spectra with the IR spectra. Figure 6 shows typical IR
spectra for noncancerous and cancerous breast tissue of the
same patient (P91) as in Figures 4 and 5. In contrast to the
results presented in Figure 5, where Raman spectra of
noncancerous and cancerous tissues differ significantly, the IR
spectra in Figure 6 are almost identical, although the
absorbance of various vibrations differs markedly.
Steady-State Absorption Measurements. Steady state
absorption spectra of AlPcS4 in water solution, in film on the
glass support, and in films at the biological interface of
noncancerous and cancerous human breast tissues are shown in
Figure 7.
The Soret band and Q band are observed at 340 and 678 nm,
respectively. The Q band (S0 → S1, (a2u) → (eg) transition) in
solution has a sharp maximum at 678 nm as well as weaker
bands in the blue side with maxima at 643 and 607 nm. We
have shown that the absorption bands are very similar in the
concentration range of 10−5−10−3 M, indicating that AlPcS4 is
dominated by a monomeric form in aqueous solution.1
Assuming the thickness of the AlPc S4 layer as 100 μm and
the absorption coefficient the same as in solution we estimated
Figure 5. Average Raman spectra of noncancerous (a) and cancerous (b) breast tissue of patient P91.
Figure 6. Comparison between the IR spectra of noncancerous and
cancerous (infiltrating ductal carcinoma) breast tissue of patient P91.
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the concentration of the photosensitizer in tissues as equal to
10−2 M.
At such a high concentration we cannot neglect effects
related to aggregation of AlPcS4. One can see from Figure 7
that in contrast to solutions, absorption spectra at the biological
interface of the tissues and in the film of pure AlPcS4 on the
glass substrate are represented by broad, structureless bands in
the region corresponding to absorption of monomers, dimers,
and aggregates of higher order. Optical and spectroscopic
properties of dimeric forms of phthalocyanines have been
reviewed by Tran Thi.106
Excited-State Dynamics of AlPcS4 at Biological
Interfaces of Human Breast Tissue and Film and in
Aqueous Solutions. Dimerization of phthalocyanines affects
effectively ultrafast dynamics of these classes of compounds. It
has been show that excited state lifetimes of phthalocyanines
homodimers are short, and in some cases, ligand to ligand
charge transfer seems to be an effective deactivation pathway.
Nikolaitchik et al. have shown that according to exciton theory
in face to face dimer transitions between the ground state and
the lower exciton state are symmetry forbidden, and the lack of
fluorescence in such systems indicates that the upper exciton
state rapidly converts to the lower one, which undergoes
subsequent nonradiative relaxation, including intersystem
crossing.107 The absence of fluorescence in cofacial dimers
was related also to the decrease of the triples quantum yields
and shortening of triplet state lifetimes and dramatic increase of
internal conversion rates by a factor of 20−300. The
enhancement of internal conversion rates may be related to
the fact that exciton splitting places the lower exciton state
closer to the ground state. The increased intersystem crossing
rate may also be a manifestation of the lowering of the energy
gap with the lower exciton state closer to the corresponding
triplet state.107 Similar observations have been made by Ma et
al. for iron phthalocyanine.108 They have shown that in
condensed phases effective intermolecular interactions and
molecular distortion result in a shortening of the excited state
lifetime and a very high intersystem crossing rate. The influence
of aggregation on femtosecond excited state dynamics has been
investigated also by Peyghambarian et al.109 They have shown
that the induced absorption signal develops as the absorption
bleaching signal decays, suggesting exciton decay into a subgap
state.109 Fluorescent phthalocyanine dimers have been
investigated by Speirs et al.110 They have shown that the
fluorescence is typical for dimers deviating from an eclipsed
cofacial structure.
In order to study energy dissipation and dynamical
alterations in the phthalocyanine structure, a system was
triggered with a laser and monitored with a time resolution of
50 fs. To obtain insight into mechanisms of energy dissipation
we monitored the dynamics of AlPcS4 in the interfacial region
of human breast tissues upon excitation at 677 nm, which
promotes the S0 → S1 transition, with the main contribution
from the (a2u) → (eg), in the Q band. Upon excitation the
molecules were probed with different time delays at different
wavelengths (570, 602, and 670 nm).
Figure 8 shows the transient absorption signals ΔA(t) of
AlPcS4 at the interface of cancerous and noncancerous tissues
and in the film at the glass support as a function of the time
delay in the pump−probe experiments when pumped with 677
nm and probed with 664 nm. The results are presented in the
full time window up to 1 ns (Figure 8a) and in the narrow
window up to 10 ps (Figure 8b).
Figure 8 shows that directly upon excitation with the laser
pump pulse at 677 nm a negative signal at 670 nm has been
recorded. The negative signal has been assigned to bleaching of
the ground state S0 due to the S0→ S1 transition in the Q band.
The bleach is instantaneous and limited by the laser pulse
width. Recovery of the bleach at 670 nm is found to be three
exponential and fitted with time constants of 130 ± 0.10 fs,
1.53 ± 0.19 ps, and 37.86 ± 5.25 ps for cancerous tissue and
110 ± 0.10 fs, 1.34 ± 0.16 ps, and 40.72 ± 7.86 ps for
noncancerous tissue. Recovery of the bleach in the AlPcS4 film
is found to be also three exponential with time constants 830 ±
100 fs, 7.31 ± 1.02 ps, and 56.03 ± 6.58 ps. This indicates that
Figure 7. Absorption spectra of AlPcS4 in noncancerous tissue (a),
cancerous tissue (b), film (c), and aqueous solution c = 10−3 M (d).
Figure 8. Transient absorption signal ΔA(t) of AlPcS4 in noncancerous (●) and cancerous (▲) human breast tissues and in film (⧫) as a function
time delay in the full time window up to 1 ns (a) and 10 ps (b), pumped at 677 nm and probed at 670 nm.
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the dynamics recovery of the ground state S0 for noncancerous
and cancerous tissues is similar. In contrast, all time constants
are shorter than those characterizing the AlPcS4 film dominated
by aggregation effects, which indicates that the dynamics of the
photosensitizer is sensitive to the specific microenvironment of
the biological tissue.
Figure 9 shows that the instantaneous bleach of the negative
signal of AlPcS4 in water at 670 nm is accompanied by a sudden
rise at 602 nm that is followed by decay.
The positive signal has been assigned to the excited state
absorption (ESA) of the excited state S1 generated by the S0→
S1 transition in the Q band. The results clearly demonstrate
that the dynamics of AlPcS4 in noncancerous tissue is markedly
faster than that in cancerous tissue. These decays are found to
be three exponential and fitted with time constants of 810 ± 40
fs, 5.63 ± 5.49 ps, and 59.90 ± 12.85 ps for cancerous tissue
and 176 ± 20 fs, 847 ± 422 fs, and 6.03 ± 1.92 ps for
noncancerous tissue. In the contrast to biological interfaces, the
film of AlPcS4 exhibits a negative bleaching signal with recovery
described by the three exponential with time constants 163 ±
25 fs, 1.56 ± 0.42 ps, and 21.59 ± 4.14 ps.
4. DISCUSSION
In order to elucidate further electronic dynamics features that
can be rationalized from signals of the transient absorption
ΔA(t) presented in the previous section, we need to
understand the details of the electronic transitions in
phthalocyanines that are induced and probed by the laser
pulses in the pump−probe experiments. Molecular orbitals of
selected phthalocyanines are known according to calculations
from the literature.1,45,64−66 Figure 10 shows Kohn−Sham
orbitals from our TD DFT calculations.1
Figure 11 shows the comparison of the transient absorption
signal ΔA(t) of AlPcS4 as a function time delay in
noncancerous and cancerous human breast tissues, in the
film, and in aqueous solution.
Recovery of the bleach of AlPcS4 in solution at 670 nm was
fitted as a two exponential function with time constants of 5.09
± 0.99 and 203.16 ± 18.75 ps1 and as a three exponential
function with 4.27 ± 1.68, 47.21 ± 124.44, and 232.52 ± 81.00
ps. Fitting data in the early time window extending to 2 ps
found that initial recovery of the signal of AlPcS4 in water
solution at 570 nm is monoexponential and can be fitted with a
time constant of 405 ± 164 fs in water.1 The time constants in
solution are on the same order as those obtained by Howe et
al.55 for PcS4 and ZnPcS4 in DMSO probed at 720, 790, and
820 nm.
The picture that emerges from the results presented so far
provides a basis for a substantial revision of the commonly
accepted assumption that the photochemistry of the bulk
properties of photosensitizers in solutions can be translated to
the interfacial region. This approach must be considerably
revised when considering the nano−bio interface of biological
tissue. The first observation that one makes when confronting
the results from the comparison in Figure 11 are noticeable
differences between the dynamics of the photosensitizer in
Figure 9. Transient absorption signal ΔA(t) of AlPcS4 in noncancerous (●) and cancerous (▲) human breast tissues and film (⧫) as a function time
delay in the full time window up to 1 ns (a) and 10 ps (b), pumped at 677 nm and probed at 602 nm.
Figure 10. Energy level diagrams of the aluminum complex of
tetrasulfonated AlPcS4; TD DFT calculations in ref 1.
Figure 11. Comparison of the transient absorption signal ΔA(t) of
AlPcS4 as a function time delay in noncancerous (●) (a) and
cancerous (▲) (b) human breast tissues, film (⧫) (c) (pumped at 677
nm and probed at 670 nm), and aqueous solution (▼) (concentration
10−3 M, pumped at 677 nm, probed at 664 nm).
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solution and that at interfacial regions of the biological tissue.
Indeed, the dynamics of AlPcS4 in solution is much slower than
that at the biological interfaces of the tissues and in the film, for
which we find no evidence of the slow component (232.52 ±
81.00 ps). This observation confirms that aggregation in the
solid phases results in shortening of the relaxation times.
Table 1 compares the time constants characterizing the
dynamics of the ground state recovery of AlPcS4 at biological
interfaces for noncancerous and cancerous tissues, in film, and
in aqueous solution. One can see that that the dynamics
recovery of the ground state S0 for noncancerous and cancerous
tissues is similar, in contrast to the dynamics of AlPcS4 in
solution, which is much slower.
A similar picture emerges from comparison between the
dynamics at biological interfaces and those in solution for the
positive ESA signal decay at 602 nm. Figure 12 shows the
comparison of the transient absorption signals ΔA(t) of AlPcS4
as a function of time delay.
The comparison between Figure 12a and 12b and Figure 12c
demonstrates that the decay of the ESA signal in AlPcS4 at
biological interfaces is markedly faster than that in solution.
The decay in solution is found to be much slower than that
observed at biological interfaces of the tissues and in the film.
This observation confirms once again that aggregation in the
solid phases results in shortening of the relaxation times.
The decay in solution has been fitted as the three exponential
function with time constants of 2.37 ± 0.71, 28.07 ± 24.18, and
345.81 ± 107.87 ps. Fitting data in the early time window
extending to 10 ps found that the initial decay of the signal at
570 nm is monoexponential and can be fitted with a time
constant of 560 ± 94 fs in water.
Table 2 compares the time constants characterizing the
dynamics of the excited state S1 decay of AlPcS4 at biological
interfaces for noncancerous and cancerous tissues, in film, and
in aqueous solution.
One can see that that the dynamics of the excited state S1
decay for noncancerous tissue is much faster than that of
cancerous tissues. The dynamics of the noncancerous tissue is
described by three time constants (176 ± 20 fs, 847 ± 422 fs,
6.03 ± 1.92 ps) and does not contain slow components that are
observed in cancerous tissue (59.90 ± 12.85 ps), in film (21.59
± 4.14 ps), and in solution (28.07 ± 24.18 and 345.81 ±
107.87 ps).
The picture that emerges from the results presented in the
paper is as follows. The dynamics of AlPcS4 in the excited state
at biological interfaces reveals three different time scales: (a) a
very fast component of a hundred femtoseconds, (b) a few
picoseconds, and (c) 20−60 ps, in contrast to the dynamics in
solutions that exhibits an additional component in the range of
a few hundred picoseconds. The fast femtosecond component
has been also reported in the literature.1,68,70,111 Savolainen et
al.68 assigned the shortest time constant to inertial response of
solvation. Fournier et al.111 assigned a constant of <210 fs
observed in NiPc and CuPc to the lifetime S2 → S1 internal
conversion. Rao et al.70 assigned the time constant < 170 fs to
phase relaxation of Sn states. Our results on the AlPcS4
dynamics in aqueous and organic solutions1 demonstrate that
the fast femtosecond component is not sensitive to the
solvation dynamics as the time constants are almost identical in
various solvents. Thus, we find it unlikely that it is assigned to
inertial response of solvation. We assigned the femtosecond
component of the ESA signal for AlpcS4 in solution to
vibrational wavepacket dynamics of higher electronic states of
AlPcS4 immediately upon excitation.
1 However, detailed
inspection into the results presented in Tables 1 and 2
demonstrates that the dynamics in confined environments at
the biological interface of the tissue is markedly different from
that observed in solutions. The ultrafast femtosecond
component in biological tissue is clearly visible both in the
Table 1. Comparison of Time Constants of AlPcS4 at Biological Interfaces for Noncancerous and Cancerous Tissues, Film
(pump 677 nm, probe 670 nm), and Solution (pump 678 nm, probe 660 nm)
time constants
noncancerous tissue 110 ± 10 fs 1.34 ± 0.16 ps 40.72 ± 7.86 ps
cancerous tissue 130 ± 0.1 fs 1.53 ± 0.19 ps 37.86 ± 5.25 ps
film 830 ± 100 fs 7.31 ± 1.02 ps 56.03 ± 6.58 ps
solution1 4.27 ± 1.68 ps 47.21 ± 124.44 ps 232.52 ± 81.00 ps
Figure 12. Comparison of the transient absorption signal ΔA(t) of
AlPcS4 as a function of time delay in noncancerous (●) (a) and
cancerous (▲) (b) human breast tissues (pumped at 677 nm and
probed at 602 nm), and aqueous solution (▼) (c) (concentration 10−3
M, pumped at 677 nm, probed at 570 nm).
Table 2. Comparison of Time Constants of AlPcS4 at Biological Interfaces Od the Noncancerous and Cancerous Tissues, Film
(pump 677 nm, probe 602 nm), and Solution (pump 678 nm, probe 571 nm)
time constants
noncancerous tissue 176 ± 20 fs 847 ± 422 fs 6.03 ± 1.92 ps
cancerous tissue 810 ± 40 fs 5.63 ± 5.49 ps 59.90 ± 12.85 ps
film 163 ± 25 fs 1.56 ± 0.42 ps 21.59 ± 4.14 ps
solution1 560 ± 94 fs 2.37 ± 0.71 ps 28.07 ± 24.18 ps 345.81 ± 107.87 ps
 8
dynamics of the excited state S1 probed at 602 nm and in the
ground state S0 recovery probed at 670 nm. It indicates that the
interpretation of the ultrafast component as originating only
from the vibrational wavepacket dynamics of the higher
electronic states of AlPcS4 immediately upon excitation used
for the solution1 cannot be directly translated to the confined
and solid phases of biological interfaces. Taking into account
that we find no evidence of the slow component in energy
dissipation of AlPcS4 in noncancerous tissue that was reported
for many phthalocyanines in solution (232 ps,1 2.9 ns,68
Howe55), it is possible that the ultrafast component of 110 fs
recorded in the dynamics of the ground state S0 (Table 1) in
noncancerous tissue is related to the specific channel of energy
dissipation via radiationless decay at a conical intersection.111 In
contrast, in cancerous tissue the ultrafast component is not
recorded in the dynamics of excited state S1 (Table 2). It is
obviously that the time constant of 810 fs, which is markedly
larger, must reflect a different pathway of energy dissipation of
AlPcS4 in cancerous tissue. It is well known that the
phthalocyanine based photosensitizers are effective in photo
dynamic therapy3−77 when the excited molecule transfers its
excess energy to the ground state of the molecular oxygen 3O2
producing the excited state singlet oxygen 1O2. In this reaction
(called Type II reaction) the photosensitizer goes through
intersystem crossing from the excited state S1 to the triplet
state T1 followed by regeneration of ground state S0.
112 Thus, it
is possible that the 810 fs component is the intersystem
crossing time. It is worth emphasizing that the 847 ± 422 fs
component exists also in noncancerous tissue, indicating that
intersystem crossing gives some contribution as a photo
chemical pathway also in normal tissue, but the dynamics of the
excited state is evidently dominated by the ultrafast component
of 176 fs (Table 2).
Although the primary mechanism of action of PDT is related
to selective accumulation of photosensitizers in cancer tissue,113
it is not clear whether the photochemical pathways of energy
dissipation upon light excitation are the same in the normal and
cancerous tissue. The answer to this long standing question,
which is a key challenge in clinical applications, will become
clearer through analysis of the results presented above that can
identify the pathways of photodynamic reactions in regions
containing normal and malignant cells.
To obtain deeper inside into the physical meaning of the
ultrafast component in the dynamics of the excited state of the
noncancerous tissue let us first analyze a full picture of primary
events in the time window up to 1 ns. In view of the results
presented so far one can see (Tables 1 and 2) that the ultrafast
component is followed by the events occurring within a few
picoseconds. The time components in the range of 1−7 ps
obtained for AlPcS4 at different wavelengths are similar to that
reported in the literature for many phthalocyanines.1,49,68
Savolainen et al.68 assigned the time constant of 2.5 ps to
dielectric response of solvation. Rao et al.70 assigned the time
constant of 3−5 ps to vibrational relaxation. Howe and Zhang55
assigned the time constant of 10 ps to the lifetime for the S2→
S1 internal conversion. We assigned the time constants of
AlPcS4 in solutions in the range 1−7 ps to vibrational
relaxation.1 Thus, the same assignment has been applied for
the results presented in this paper for AlPcS4 at biological
interfaces.
The time constants observed in solutions in the range of
150−500 ps have been assigned1,55 to decay from S1 to the
ground state. It is worth emphasizing that this slow component
of a few hundred picoseconds (345.81 ± 107.87 ps for AlPcS4
in water) does not exist at biological interfaces. The slowest
components in noncancerous tissue obtained from the excited
state dynamics is 6.03 ± 1.92 ps and correspond to vibrational
relaxation in the excited state. The vibrational relaxation of 5.63
± 5.49 ps in cancerous tissue is similar, but the excited state
dynamics contains also the relatively slow component of 59.90
± 12.85 ps. Comparison of the time constants indicates that the
return from the excited state S1 to the ground state at the
biological interface of noncancerous tissue is very fast in
contrast to cancerous tissue. The short lifetimes of the excited
state must be related to facilitated radiationless transitions that
are usually provided by some special features of the potential
energy surfaces such as the conical intersections.111 The
mechanisms that lead to a decrease in the energy gap between
the excited state and the ground state energy surfaces are
related to the coupling between the electronic excited state and
the vibrational modes. When the potential energy surfaces
approach each other transitions are facilitated by their close
proximity and the rate of nonradiative transitions increases.98
These very fast nonradiative processes with particularly short
excited state lifetimes, which quickly dissipate the energy of the
photon into small quanta of heat, represent the main channel
that maintains the fundamental property of biological systems,
photostability. Molecular structures responsible for harvesting
of the solar energy must be photostable and resistant to
photoinduced chemical changes and must find a specific way
for recovery via relaxation and energy dissipation upon optical
excitation.98 Many important features of biological sys
tems111,114−116 can be explained with the idea of the conical
intersection and avoided crossing. Worth and Cederbaum, for
instance, proposed the conical intersection is an important
feature for mediation of ultrafast electron transfers.114
Abramczyk98,115−119 has shown that the decrease in the energy
gap between the excited state and the ground state energy
surfaces due to the vibronic coupling plays a crucial role in
understanding light energy dissipation in many biological
systems, particularly in H bonded systems, and light initiated
biological photoreceptors such as bacteriorhodopsin. Sobolew
ski et al.120 have shown that conical intersections may be
responsible for the mechanism of nonradiative decay of DNA
bases.
An open question is how the biological environment affects
the topography of the potential energy surfaces of the ground
and excited state of the photosensitizer. Figure 13 illustrates the
topographies with peaked and sloped conical intersections.
Figure 13a illustrates the situation when the crossing point is
the lowest energy point on the excited state. In this case several
channels may arise on the ground state from the crossing,
resulting in various photoproducts. This kind of peaked
intersection may result in degradation of the photosensitizer,
which is bad for its photostability. At another topography
(Figure 13b) the single point intersection may lead to efficient
transitions from the excited state to the ground state with only
one reaction product. On the other side, the sloped conical
intersections that occur when more than two molecular
vibrations are involved in the conical intersection may form a
high dimensional ‘seam’ between the two states, rather than a
single point.121 Some authors believe that ideal photostability
goes through a sloped intersection122 with only one relaxation
channel on the ground state leading back to reactant. In
contrast, the others argue that sloped topographies direct the
excited molecule toward the intersection less efficiently because
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the molecule is more likely to ‘miss’ the intersection, and this
topography leads to a wider variety of reaction products and
lower photostability.121
In order to rationalize the experimental results obtained in
this paper we propose the following picture for the primary
events responsible for energy dissipation of the photosensitizer
in noncancerous and cancerous tissues. Figure 14 illustrates the
main channels of energy dissipation once upon light excitation
of AlPcS4 in aqueous solution and at the interfacial regions of
the biological tissue.
In aqueous solution (Figure 14c), after photon absorption,
the excited state Sn relaxes rapidly within 560 fs in the Franck−
Condon region followed by vibrational relaxation in the S1 state
with a time constant of 2.4 ps and return to the ground state S0
via fluorescence with the excited state lifetime of 345 ps. The
second channel of energy dissipation goes through intersystem
crossing to the triplet state T1 followed by return to the
ground state S0 via phosphorescence with the excited triplet
state T1 lifetime of 28 ps. The phthalocyanine at biological
interfaces of the human breast tissue does not relax via
fluorescence. In cancerous tissue (Figure 14b) after photon
absorption the excited state Sn relaxes in the Franck−Condon
region followed by intersystem crossing within 810 fs to the
triplet state T1 followed by return to the ground state S0 via
phosphorescence with the excited triplet state T1 lifetime of
59.9 ps. The second channel goes through vibrational relaxation
in the S1 state with a time constant of 5.6 ps followed by the
conical intersection to the ground state S0 and vibrational
relaxation in the ground state within 1.5 ps. In the
noncancerous tissue (Figure 14a) the main channel is
radiationless decay via conical intersection with time constants
Figure 13. Peaked (a, b) and sloped conical intersections (c).
Figure 14. Comparison of the transient absorption signal ΔA(t) of AlPcS4 as a function of time delay in noncancerous (●) (a) and cancerous (▲)
(b) human breast tissues (pumped at 677 nm and probed at 602 nm) and aqueous solution (▼) (c) (concentration 10−3 M, pumped at 677 nm,
probed at 570 nm). Excited state relaxation mechanisms in solution (A), normal (noncancerous) tissue (B), and cancerous human breast tissue (C).
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of 176 fs and 6 ps corresponding to wave packet dynamics in
the Franck−Condon region of the S1 state and vibrational
relaxation of the excited state S1, crossing the local barrier
followed by relaxation to the conical intersection, respectively.
The constant of 1.3 ps along this pathway corresponds to
vibrational relaxation in the ground state S0. The second
channel active in noncancerous tissue is intersystem crossing to
the triplet state T1 within 847 fs and with time constants of 41
and 1.3 ps corresponding to the lifetime of T1 and the ground
vibrational relaxation state, respectively.
A question arises why the photochemical channels of energy
dissipation of the photosensitizer at the interface of the normal
and cancerous tissues are different. Although interactions at
cellular surfaces involve large numbers of forces and molecular
interactions, successful use of photosensitizers to achieve
measurable biological responses, as presented in this report,
indicates that it is indeed possible to probe the nano−bio
interface experimentally. At first glance, interactions between
the photosensitizer and cell surfaces seem to embody similar
principles as those between molecules in hydrophobic and
hydrophilic environments. Figure 4a demonstrates that normal
breast tissue consists of fatty tissue with embedded ducts and
blood vessels. Fatty tissue is hydrophobic as it is formed of
glycerol monooleate (GMO).99 In contrast, cancerous tissue is
dominated by epithelial cells, which produce milk and are lined
with the ducts of the breast (Figure 4b). The surface of
cancerous tissue is hydrophilic,100 and the level of various
proteins is markedly elevated during disease development. We
found100 that water amount confined in cancerous tissue is
markedly higher than that in noncancerous tissue. Our results
provide experimental evidence for the role played by the lipid
profile and cell hydration as factors of particular significance in
differentiation of noncancerous and cancerous breast tissues.
Thus, the hydrophilic phthalocyanine such as AlPcS4 at the
hydrophilic cancerous breast tissue exhibits dynamics more
similar to that in aqueous solution than that at the hydrophobic
noncancerous breast tissue. The hydrophilic AlPcS4 phthalo
cyanine displayed no binding with membranes formed of
glycerol monooleate (GMO),123 which are the main con
stituent of fatty tissues in the normal tissue. It indicates that
hydrophilic photosensitizers interact weakly with the constit
uents of normal breast tissue at the hydrophobic biological
interface. It has been demonstrated124 that weak interactions
between the hydrophilic and the hydrophobic molecules lead to
interesting interfacial behavior. It has been shown that at the
contact with the hydrophobic surface the interfacial hydrophilic
molecule (water) shows very weak bonding character with
other water molecules. A similar mechanism may drive weaker
coupling between the hydrophilic molecules of the photo
sensitizer resulting in less efficient coupling with the environ
ment and a decrease in the energy barrier on the single excited
state S1 profile. The decrease in the height of the energy barrier
may lead to a more efficient channel via conical intersection
with radiationless decay.
This conclusion is supported by the fluorescence image for
the photosensitizer ZnPcS4 at the interface of cancerous and
noncancerous tissues presented in Figure 15.
Figure 15. Fluorescence images and spectra of the cancerous (a) and normal (noncancerous) (b) breast tissues of patient P80.
 11
The colors represent different intensities of fluorescence of
the Q band. The colors in the florescence images correspond to
the colors of the fluorescence spectra. One can see that in
cancerous tissue almost all regions of the tissue are fluorescent
(Figure 15a). In contrast, in noncancerous tissue most regions
under study do not reveal any fluorescence (Figure 15b).
5. CONCLUSIONS
The excited state dynamics of the tetrasulfonated aluminum
phthalocyanine (AlPcS4) have been studied at the biological
interface of human breast tissue by Raman, IR, fluorescence,
and pump−probe transient absorption laser spectroscopies,
providing information about the events occurring in time scale
ranging from femtoseconds to nanoseconds. We found that the
dynamics in the interfacial regions of the biological tissue is
markedly shorter than that in solution.
We found that photosensitizers responsible for harvesting of
the light energy in biological tissue find their way for recovery
through some special features of the potential energy surfaces
such as conical intersections, which facilitate the rate of
radiationless transitions. We found that the tetrasulfonated
aluminum phthalocyanine interacts with normal (noncancer
ous) breast tissue and cancerous tissue according to different
pathways.
The dynamics in noncancerous tissue is dominated by
radiationless decay at a conical intersection, in contrast to the
dynamics in solutions, which is dominated by the fluorescence.
The dynamics in cancerous tissue is dominated by the
phosphorescence from the triplet state T1. We found that the
dynamics of AlPcS4 reveals three time scales: 110−170 fs, 1−7
ps, and 20−60 ps. The shortest time constants have been
assigned to vibrational wavepacket dynamics in the Franck−
Condon region down to the local minimum of the excited state
S1, a few picosecond component has been assigned to
vibrational relaxation in the ground and excited electronic
states, and 20−60 ps components represent decay from the
triplet state T1 to ground state S0.
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